We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFRWW
13051
DELISTED
Appreciate Holdings, Inc. Warrant
SFRWW
$9.19K ﹤0.01%
918,603
-4,185
-0.5% -$60
IGMS
13052
PUT
DELISTED
IGM Biosciences
IGMS
$9.19K ﹤0.01%
1,100
-800
-42% -$6.79K
SKIL icon
13053
CALL
Skillsoft
SKIL
$74.2M
$9.13K ﹤0.01%
515
-1,360
-73% -$34.5K
ENFY
13054
CALL
DELISTED
Enlightify Inc
ENFY
$9.06K ﹤0.01%
4,000
+3,300
+471% +$8.09K
TAIL icon
13055
CALL
Cambria Tail Risk ETF
TAIL
$146M
$9.06K ﹤0.01%
700
-1,000
-59% -$13.3K
ASXC
13056
PUT
DELISTED
Asensus Surgical, Inc.
ASXC
$9.04K ﹤0.01%
33,500
+7,100
+27% +$2.58K
FTCI icon
13057
FTC Solar
FTCI
$38.7M
$8.97K ﹤0.01%
701
-913
-57% -$22.1K
AURA icon
13058
PUT
Aura Biosciences
AURA
$797M
$8.97K ﹤0.01%
1,000
MRDB
13059
DELISTED
MariaDB plc
MRDB
$8.96K ﹤0.01%
+18,668
New +$13.8K
RBB icon
13060
CALL
RBB Bancorp
RBB
$467M
$8.95K ﹤0.01%
+700
New +$9.52K
PTVE
13061
CALL
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$8.94K ﹤0.01%
1,100
-100
-8% -$817
ENTA icon
13062
CALL
Enanta Pharmaceuticals
ENTA
$383M
$8.94K ﹤0.01%
800
-1,000
-56% -$16.1K
HYFM icon
13063
PUT
Hydrofarm Holdings
HYFM
$7M
$8.91K ﹤0.01%
730
+120
+20% +$1.34K
CLNN icon
13064
CALL
Clene
CLNN
$52.9M
$8.88K ﹤0.01%
895
-125
-12% -$1.73K
LIDR icon
13065
PUT
AEye
LIDR
$60.9M
$8.86K ﹤0.01%
1,407
+1,324
+1,595% +$10.6K
SCLX icon
13066
PUT
Scilex Holding
SCLX
$47.5M
$8.82K ﹤0.01%
180
-1,017
-85% -$139K
NRSN icon
13067
NeuroSense Therapeutics
NRSN
$17.1M
$8.78K ﹤0.01%
+11,702
New +$12.3K
ATRC icon
13068
CALL
AtriCure
ATRC
$2.25B
$8.76K ﹤0.01%
200
-1,300
-87% -$63.4K
USIO icon
13069
CALL
Usio Inc
USIO
$78.6M
$8.75K ﹤0.01%
5,000
-3,800
-43% -$6.46K
BCDAW
13070
DELISTED
BioCardia, Inc. Warrant
BCDAW
$8.73K ﹤0.01%
46,730
+10,658
+30% +$5.55K
DSGN icon
13071
PUT
Design Therapeutics
DSGN
$928M
$8.73K ﹤0.01%
3,700
-500
-12% -$2.33K
KAVL
13072
DELISTED
Kaival Brands Innovations Group
KAVL
$8.72K ﹤0.01%
+984
New +$12.3K
UK icon
13073
Ucommune International Ltd Class A Ordinary Shares
UK
$1.52M
$8.72K ﹤0.01%
+242
New +$10.3K
SINT icon
13074
SiNtx Technologies
SINT
$10.4M
$8.71K ﹤0.01%
56
-54
-49% -$12.6K
AVIR icon
13075
PUT
Atea Pharmaceuticals
AVIR
$411M
$8.7K ﹤0.01%
2,900
-3,000
-51% -$10.2K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.